Published: January 2021

This Advisory is based on TIP 39, Substance Use Disorder Treatment and Family Therapy. It surveys basic factors for programs and providers to consider when implementing family-related therapy approaches, goals and processes for conducting effective family counseling, and resources for further learning about family therapy techniques and models.

Published: January 2021

This Advisory, based on TIP 49, Incorporating Alcohol Pharmacotherapies Into Medical Practice, focuses on medication and related treatment decisions made after screening and assessment for AUD, and medically supervised withdrawal, if necessary. Alcohol consumption should not stop abruptly in those patients who have consumed alcohol regularly over a prolonged period of time. This Advisory is meant as an overview of AUD medications to facilitate abstinence.

Published: November 2015

This advisory defines attention deficit hyperactivity disorder in adults, and explains interactions with substance use disorders.

Published: May 2012

This advisory answers questions about the seriousness of prescription drug misuse. It explains how people become dependent on prescription drugs, and treatment options. The advisory also offers necessary treatment resources for professionals.

Published: June 2010

This manual provides physicians with quick reference information about three FDA-approved medications to help patients achieve abstinence from alcohol: acamprosate, disulfiram, and naltrexone (oral and extended-release). It also includes patient management tips.

Published: August 2008

This advisory gives substance use treatment and service providers updated facts about OxyContin. It describes its use and misuse, addiction and dependency, withdrawal symptoms, and treatment and detoxification protocols, including medication-assisted treatment.